Bisphosphonate-Associated Osteonecrosis

What Bisphosphonate-Associated Osteonecrosis Means

Bisphosphonate-associated osteonecrosis (BON) is a condition where bone tissue dies, most often in the jaw, as a side effect of bisphosphonate drugs. Bisphosphonates are medicines that slow down the natural process of bone breakdown, helping to keep bones stronger. They are commonly used to treat osteoporosis, bone pain caused by some cancers, and high blood calcium levels. While these drugs protect bones, in some cases they can interfere with the bone’s ability to heal, leading to areas of dead bone tissue called osteonecrosis.

Why BON Matters in Cancer Care

In cancer treatment, bisphosphonates are important for reducing bone complications when cancer spreads to bones or causes high calcium levels. BON is a known but uncommon risk of these drugs. The jaw is the most common site affected, possibly because it undergoes frequent stress from chewing and dental procedures. BON can cause pain, swelling, infection, and sometimes exposed bone, which can affect eating and speaking. Because bisphosphonates provide important benefits, doctors carefully monitor patients for signs of BON during treatment.

Recognizing BON and Its Symptoms

Patients might notice jaw pain, swelling, or infection. Sometimes, dead bone may be visible in the mouth. These symptoms should prompt a visit to a healthcare provider or dentist. BON can develop after dental work or sometimes without clear cause. It is important to maintain good oral hygiene and inform your dentist and doctor if you are taking bisphosphonates before any dental procedures to help reduce risk.

How BON Is Managed and Monitored

If BON is suspected, your healthcare team may perform a physical exam and imaging tests to check the jaw bones. Treatment may include temporarily stopping bisphosphonate therapy, managing infections with antibiotics, pain control, or other supportive care. Preventive dental exams and necessary dental work before starting bisphosphonates can lower the chance of developing BON. Regular communication between your cancer care team and dental providers is important for safe treatment.

Understanding BON in Context

Not everyone who takes bisphosphonates will develop BON. Hearing the term BON or its abbreviation can be confusing or worrying, but it does not mean the medication is unsafe for all patients. It is a rare side effect that requires monitoring and good dental care. BON is different from common dental infections or other bone diseases, so understanding its specific cause and treatment helps avoid confusion.

Questions to Ask Your Care Team

You might ask your healthcare providers about your personal risk for BON, what symptoms to watch for, and how to protect your jaw health during treatment. Questions like "What signs should I report?" or "How can I reduce my risk of jaw problems?" can guide your care. Always share your bisphosphonate use with your dentist before any dental work.

Important Safety Information

This information is educational and does not replace personalized medical advice. If you have concerns about bisphosphonate treatment or notice jaw pain, swelling, or other symptoms, contact your healthcare provider promptly. Understanding BON helps you take an active role in your care and work with your team to manage your treatment safely.